Medicare Drug Price Negotiation Program
Stories
-
CMS codifies Medicare Drug Price Negotiation Program for 2029
On Nov. 5 2026, the Centers for Medicare & Medicaid Services issued a final rule (CMS-4215-F) that codifies the Negotiation Program for the initial price applicability year 2029 and beyond, effective Dec. 5 2026. The rule also establishes new policies for selecting up to 20 drugs for negotiation each year and clarifies procedures for manufacturers and the publication of negotiated maximum fair prices.
-
CMS final rule strengthens supports lasting drug savings
The CMS final rule establishes a permanent framework for negotiating prices of high-cost drugs, with policies taking effect in 2029. By Feb. 1, 2027, CMS will select up to 20 additional negotiation-eligible drugs for the fourth cycle of negotiations.